When there’s a 95% failure rate for go-to-market innovations in the US, you have to wonder: what is actually happening?
Resources, tools, templates, and an abundance of accelerator programs should equal a stronger success rate, right? No, actually it doesn’t.
In fact, the flood of resources might be exactly what holds the success rate down for innovators trying to bring solutions to the market.
Jason Mellad of Start Codon, a UK-based accelerator, has experience both inside and outside of the US markets — and he brings those insights to the table this week for our viewers.
If you’ve ever wondered what the best approach to take with a potential investor is — what attitude, knowledge, position you need to bring to the table to secure funding — here’s your show!
Intelligent and passionate about delivering solid solutions and improved patient outcomes, Jason gets down to the real business of building a successful startup.
Here are the show highlights:
- The difference between the UK and US accelerator markets (1:29)
- What startups need to understand when mapping out solutions (5:34)
- How to avoid bias that can lead your startup down the wrong path (11:48)
- Why it’s so important to embrace constructive criticism (16:29)
- This is how you convince your investors to invest in research (20:52)
- Three qualities innovators need to show investors, NOT tell them (29:31)
I've spoken with dozens of health innovators, and nearly everyone is trying to figure out their best pivot strategy. But they don't know what to change, how to pivot, or if their new pivot strategy is the right move.
So I went into overdrive putting together a clear, actionable 5-step worksheet that will help you quickly define your most viable and profitable pivot path through the COVID crisis. And I’m giving it to you for FREE — no strings attached at legacy-dna.com/pivot
Jason Mellad is the CEO, Co-Founder, and Managing Partner of Start Codon, a healthcare and life sciences accelerator helping startup businesses build to succeed on a global scale.
Focused on innovative technologies and solutions that provide better patient outcomes, Start Codon is the result of Jason’s love of science and passion for entrepreneurship.
Jason earned his BSc in Molecular Biology and Chemistry from Tulane College in 2004, and his Ph.D. in Medicine from the University of Cambridge in 2009.